Internal Contraceptive Devices Can Reduce Risk Of Cervical Cancer

According to Spanish researchers who have revealed their latest findings, the use of internal contraceptive devices can help reduce cervical cancer risks. However, the researchers have also said that the device does not help in stopping the birth of the diseases. The presence of a foreign body in the uterus can act as a stimulant for inflammatory alterations that curb the aggressiveness of HPV infection. The researchers have confirmed that the contraceptive devices are not passive elements in uterus and that they actually have a role to play.Cervical cancer is one of the leading killers and is only second to breast cancer in women. The statistics stand true for women all over the world. Cervical cancer causes the death of half the women it inflicts. According to statistics, the disease strikes about 500,000 women each year, out of which 250,000 women die. The statistics have been revealed by World Health Organization. While insertion of the device is not recommended for the sole a preventive measure or a way of stopping the birth of cancer, the results of this study will encourage more women to opt for the procedure. IUD devices are made up of plastic or copper and are also called Copper Ts.

To arrive at these conclusions, case histories of 20,000 women have been studied. The agent which is known to cause cervical cancer is called HPV, which stands for Human Papilloma Virus. HPV is also the largest cause of reproductive infections. The study of cases proved that those who used the intravenous device were less likely to develop infection from the virus. The risk was reduced by almost half.

According to the researchers, the reason behind the effectiveness of the device could be its insertion and removal process. The procedure could lead to destruction of cells in the early stages of contracting infection. The other reason is that the device, being foreign to the body, can cause inflammation and trigger the immune system of the body, thereby destroying cancer cells as well. In any case, the progress of infection is curbed.

The lead researcher Xavier Castellsague said that these results were rather surprising, more so because there has never been any correlation between insertion of the uterine device and reduction of cancer risks. Castellsague belongs to the Catalan Institute of Oncology, Barcelona.

Certain leading pharmaceutical companies such as GlaxoSmithKline and Merck have released vaccinations that develop immunity against the virus. Mass awareness drives are being carried out to administer the vaccine to girls and heighten the strength of their immunity system against the virus. The length of usage was not found to have an effect on cancer protection.